Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Foster

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Oncology|July 29, 2010
Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expressionLaleh Kamalian, Shiva S Forootan, Zheng Z Bao, et al.
Journal of the National Cancer Institute|April 4, 2002
Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicityChun Jing, Manal Abd El-Ghany, Carol Beesley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Increased expression of Id family proteins in small cell lung cancer and its prognostic significanceLaleh Kamalian, John R Gosney, Shiva S Forootan, et al.
International Journal of Oncology|February 4, 2011
Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expressionYu Zhang, Shiva S Forootan, Laleh Kamalian, et al.
International Journal of Cancer|December 7, 2005
Prognostic significance of osteopontin expression in human prostate cancerShiva S Forootan, Christopher S Foster, Vijay R Aachi, et al.
Pathology, Research and Practice|July 13, 2017
Neonatal Nav1.5 protein expression in normal adult human tissues and breast cancerRezan Fahrioglu Yamaci, Scott P Fraser, Esra Battaloglu, et al.
Human Pathology|June 30, 2007
Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancerShiva S Forootan, Yong-Chuan Wong, Andrew Dodson, et al.
International Journal of Oncology|December 4, 2009
Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenograftsShiva S Forootan, Zheng Z Bao, Farzad S Forootan, et al.
Oncotarget|October 7, 2016
A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factorsAmar S Ahmad, Nataša Vasiljević, Paul Carter, et al.
Biomarkers in Medicine|November 18, 2014
DNA methylation of PITX2 predicts poor survival in men with prostate cancerNataša Vasiljević, Amar S Ahmad, Paul D Carter, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Oncology|July 29, 2010
Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expressionLaleh Kamalian, Shiva S Forootan, Zheng Z Bao, et al.
Journal of the National Cancer Institute|April 4, 2002
Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicityChun Jing, Manal Abd El-Ghany, Carol Beesley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Increased expression of Id family proteins in small cell lung cancer and its prognostic significanceLaleh Kamalian, John R Gosney, Shiva S Forootan, et al.
International Journal of Oncology|February 4, 2011
Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expressionYu Zhang, Shiva S Forootan, Laleh Kamalian, et al.
International Journal of Cancer|December 7, 2005
Prognostic significance of osteopontin expression in human prostate cancerShiva S Forootan, Christopher S Foster, Vijay R Aachi, et al.
Pathology, Research and Practice|July 13, 2017
Neonatal Nav1.5 protein expression in normal adult human tissues and breast cancerRezan Fahrioglu Yamaci, Scott P Fraser, Esra Battaloglu, et al.
Human Pathology|June 30, 2007
Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancerShiva S Forootan, Yong-Chuan Wong, Andrew Dodson, et al.
International Journal of Oncology|December 4, 2009
Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenograftsShiva S Forootan, Zheng Z Bao, Farzad S Forootan, et al.
Oncotarget|October 7, 2016
A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factorsAmar S Ahmad, Nataša Vasiljević, Paul Carter, et al.
Biomarkers in Medicine|November 18, 2014
DNA methylation of PITX2 predicts poor survival in men with prostate cancerNataša Vasiljević, Amar S Ahmad, Paul D Carter, et al.
Pageof 8